Insulet (Nasdaq:PODD) once again posted significant year-over-year growth as Omnipod revenues continue to rise.
Johnson & Johnson MedTech announced today that the FDA approved its Varipulse pulsed field ablation (PFA) platform for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback